Caltagirone SpA (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price on Sep 20, 2024

CALT Revenue

Calliditas Therapeutics AB had revenue of 1.09B EUR in the half year ending June 30, 2025, with 14.51% growth. This brings the company's revenue in the last twelve months to 2.22B, up 12.16% year-over-year. In the year 2024, Calliditas Therapeutics AB had annual revenue of 2.11B with 8.54% growth.

Revenue (ttm)
2.22B EUR
Revenue Growth
+12.16%
P/S Ratio
0.48
Revenue / Employee
564,684 EUR
Employees
3,925
Market Cap
1.26B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.11B165.97M8.54%
Dec 31, 20231.94B3.73M0.19%
Dec 31, 20221.94B364.11M23.10%
Dec 31, 20211.58B141.77M9.88%
Dec 31, 20201.43B-22.01M-1.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition